Innisfree M&A Incorporated

United Statesinnisfreema.com

Innisfree M&A Incorporated is a proxy solicitation and shareholder communications advisory firm. It supports public companies, boards, and investors on matters requiring shareholder votes, including mergers and acquisitions, tender offers, contested director elections, shareholder activism, and annual or special meetings. The firm also serves as an information agent, conducts investor outreach, tracks and analyzes voting outcomes, and provides guidance on corporate governance and engagement strategies.

Active across sectors—including chemicals and industrials—Innisfree helps issuers communicate with institutional and retail shareholders, navigate regulatory and proxy-advisory dynamics, and execute solicitation campaigns in U.S. and international markets.

Latest news on Innisfree

6 August 2026
argenx launches $77-per-share tender offer for Forte

Commences cash offer of $77 per share; merger to follow subject to HSR clearance and a >50% tender condition.

24 June 2026
GSK commences tender offer for Nuvalent

Tender offer launched at $124 per share; requires majority of Class A shares tendered and HSR clearance; no guaranteed delivery; offer set to expire July 14, 2026.